The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds in a cellular system

Output Details

Preprint June 17, 2022

Published February 2, 2023

Amyloid-like aggregates of the microtubule-associated protein Tau are associated with several neurodegenerative disorders including Alzheimer’s disease. The existence of cellular machinery for the removal of such aggregates has remained unclear, as specialized disaggregase chaperones are thought to be absent in mammalian cells. Here we show in cell culture and in neurons that the hexameric ATPase valosin-containing protein (VCP) is recruited to ubiquitylated Tau fibrils, resulting in their efficient disaggregation. Aggregate clearance depends on the functional cooperation of VCP with heat shock 70 kDa protein (Hsp70) and the ubiquitin-proteasome machinery. While inhibition of VCP activity stabilizes large Tau aggregates, disaggregation by VCP generates seeding-active Tau species as byproduct. These findings identify VCP as a core component of the machinery for the removal of neurodegenerative disease aggregates and suggest that its activity can be associated with enhanced aggregate spreading in tauopathies.
Tags
  • Original Research

Meet the Authors

  • Itika Saha, PhD

    Key Personnel: Team Harper

    Max Planck Institute of Biochemistry

  • Patricia Yuste Checa, PhD

    Key Personnel: Team Harper

    Max Planck Institute of Biochemistry

  • User avatar fallback logo

    Miguel Da Silva Padilha

  • User avatar fallback logo

    Qiang Guo

  • User avatar fallback logo

    Roman Körner

  • User avatar fallback logo

    Hauke Holthusen

  • Victoria Anne Trinkaus, MSc

    Key Personnel: Team Harper

    Max Planck Institute of Biochemistry

  • User avatar fallback logo

    Irina Dudanova

  • Ruben Fernandez-Busnadiego, PhD

    Co-PI (Core Leadership): Team Harper

    University of Gottingen

  • User avatar fallback logo

    Wolfgang Baumeister

  • User avatar fallback logo

    David W. Sanders

  • User avatar fallback logo

    Saurabh Gautam

  • User avatar fallback logo

    Marc I. Diamond

  • Franz-Ulrich Hartl, MD

    Co-PI (Core Leadership): Team Harper

    Max Planck Institute of Biochemistry

  • User avatar fallback logo

    Mark S. Hipp